Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Katalin Pungor"'
Autor:
Katalin Pungor, Pedro Sanchez, Sofia Pappa, Jerome Attal, Karolina Leopold, Geertje Steegen, Antonio Vita, Carol Marsella, Caroline Verrijcken, Marjolein Lahaye, Annette Wooller
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background To understand the implications of switching from paliperidone palmitate 1-monthly (PP1M) to paliperidone palmitate 3-monthly (PP3M) treatment of schizophrenia from the perspective of four key stakeholders: patients, physicians, nu
Externí odkaz:
https://doaj.org/article/57e63c84a17d410db14ac91b3e7237cf
Autor:
Rebekka Lencer, Maria Paz Garcia-Portilla, Paul Bergmans, Srihari Gopal, Maju Mathews, Annette Wooller, Katalin Pungor
Publikováno v:
Comprehensive Psychiatry, Vol 107, Iss , Pp 152233- (2021)
Rationale: Reducing the frequency of long-acting injectable antipsychotic medication may reduce carer burden. Objectives: To evaluate the impact of reduced frequency of long-acting injectable antipsychotic medication on carer burden in stable patient
Externí odkaz:
https://doaj.org/article/51ab9250a21847269b9ad3fa8a1bb76a
Autor:
Katalin Pungor, Vasilis P. Bozikas, Robin Emsley, Pierre-Michel Llorca, Srihari Gopal, Maju Mathews, Annette Wooller, Paul Bergmans
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Background: Paliperidone palmitate 3-monthly (PP3M) is a second-generation, long-acting injectable antipsychotic formulation indicated for the maintenance treatment of adults with schizophrenia first stabilized with paliperidone palmitate 1-monthly (
Externí odkaz:
https://doaj.org/article/b3fa4be270c14f9fa42165c0eeb276ea
Autor:
Maria Paz Garcia-Portilla, Pierre-Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Ozguven, Sung-Wan Kim, Paul Bergmans, Irina Usankova, Katalin Pungor
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Background: Paliperidone palmitate 3-monthly (PP3M) formulation is a long-acting, injectable antipsychotic treatment approved in many countries worldwide for the maintenance treatment of adult patients with schizophrenia. This single-arm, open-label,
Externí odkaz:
https://doaj.org/article/9b1afb3a4e6044e6b005a52cf7c7ab9a
Autor:
Christoph U, Correll, István, Bitter, Fabian, Hoti, Juha, Mehtälä, Annette, Wooller, Katalin, Pungor, Jari, Tiihonen
Publikováno v:
Schizophrenia Research. 250:67-75
Schizophrenia is associated with a wide range of socioeconomic and health-related problems, as well as 10-25 potential life-years lost. While lifestyle choices, comorbidities, and choice of medication are associated with schizophrenia disease burden
Autor:
Katalin Pungor, Jennifer Lee, Tom Denee, Yerkebulan Kambarov, Riikka Nissinen, Kevin Ampeh, Marco Pellegrini, Francesco Parmeggiani
Retina specialists (n = 20) and geneticists (n = 5) in France, Germany, Italy, Spain, and the United Kingdom were interviewed to provide insights on real-world patients (n = 80) with X-linked retinitis pigmentosa (XLRP). Survey respondents reported t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f48fb54b1a6770959728dc23e797de2b
https://doi.org/10.21203/rs.3.rs-1665937/v1
https://doi.org/10.21203/rs.3.rs-1665937/v1
Autor:
Arun Singh, Wilson Tan, Adam Savitz, Maju Mathews, Srihari Gopal, Isaac Nuamah, Bernardo Soares, Katalin Pungor, Edward Kim
Publikováno v:
Neuropsychiatric Disease and Treatment
Maju Mathews,1 Srihari Gopal,2 Arun Singh,3 Isaac Nuamah,4 Katalin Pungor,5 Wilson Tan,6 Bernardo Soares,7 Edward Kim,8 Adam J Savitz2 1Global Medical Affairs, Janssen Research & Development, LLC, Titusville, NJ, USA; 2Department of Neuroscience, Jan
Publikováno v:
Neuropsychiatric Disease and Treatment
Srihari Gopal,1 Jagadish Gogate,1 Katalin Pungor,2 Edward Kim,3 Arun Singh,1 Maju Mathews1 1Janssen Research and Development, LLC, Titusville, NJ, USA; 2Medical Affairs, EMEA, Janssen-Cilag, Neuss, Germany; 3Janssen Scientific Affairs, Janssen Pharma
Autor:
Arun Singh, Maju Mathews, Gang Li, Camille Orman, Mehmet Daskiran, Srihari Gopal, Isaac Nuamah, Katalin Pungor, Alexander Keenan, A. Godet, Kruti Joshi
Publikováno v:
Patient preference and adherence
Gang Li,1 Alexander Keenan,2 Mehmet Daskiran,1 Maju Mathews,3 Isaac Nuamah,3 Camille Orman,3 Kruti Joshi,4 Arun Singh,3 Annabelle Godet,5 Katalin Pungor,6 Srihari Gopal3 1Janssen Research & Development, LLC, Raritan, NJ, USA; 2Janssen Research & Deve
Autor:
Karolina Leopold, Caroline Verrijcken, Carol Marsella, Antonio Vita, Sofia Pappa, Katalin Pungor, Annette Wooller, Jerome Attal, Marjolein Lahaye, Geertje Steegen, Pedro Sánchez
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-15 (2021)
BMC Psychiatry
BMC Psychiatry
Background To understand the implications of switching from paliperidone palmitate 1-monthly (PP1M) to paliperidone palmitate 3-monthly (PP3M) treatment of schizophrenia from the perspective of four key stakeholders: patients, physicians, nurses and